BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17097181)

  • 1. Wet sol-gel derived silica for controlled release of proteins.
    Teoli D; Parisi L; Realdon N; Guglielmi M; Rosato A; Morpurgo M
    J Control Release; 2006 Dec; 116(3):295-303. PubMed ID: 17097181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.
    Morpurgo M; Teoli D; Pignatto M; Attrezzi M; Spadaro F; Realdon N
    Acta Biomater; 2010 Jun; 6(6):2246-53. PubMed ID: 20035908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro controlled release of doxorubicin from silica xerogels.
    Prokopowicz M
    J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and dynamics of lysozyme encapsulated in a silica sol-gel matrix.
    Pastor I; Ferrer ML; Lillo MP; Gómez J; Mateo CR
    J Phys Chem B; 2007 Oct; 111(39):11603-10. PubMed ID: 17850137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies on release of large and small molecules from biodegradable SiO2.
    Viitala R; Jokinen M; Rosenholm JB
    Int J Pharm; 2007 May; 336(2):382-90. PubMed ID: 17292572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.
    Contessotto L; Ghedini E; Pinna F; Signoretto M; Cerrato G; Crocellà V
    Chemistry; 2009 Nov; 15(44):12043-9. PubMed ID: 19774561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of amorphous microporous silica for ibuprofen controlled release.
    Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
    Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity.
    Catauro M; Melisi D; Curcio A; Rimoli MG
    J Biomed Mater Res A; 2008 Dec; 87(4):843-9. PubMed ID: 18200553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The controlled release of drugs from emulsified, sol gel processed silica microspheres.
    Radin S; Chen T; Ducheyne P
    Biomaterials; 2009 Feb; 30(5):850-8. PubMed ID: 19010531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biofriendly silica gel for in situ protein entrapment: biopolymer-assisted formation and its kinetic mechanism.
    Wang GH; Zhang LM
    J Phys Chem B; 2009 Mar; 113(9):2688-94. PubMed ID: 19708206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein.
    Tang Y; Singh J
    Int J Pharm; 2009 Jan; 365(1-2):34-43. PubMed ID: 18786623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating formation and drug-release behavior of new sol-gel silica matrix by hydroxypropyl guar gum.
    Wang GH; Zhang LM
    J Phys Chem B; 2007 Sep; 111(36):10665-70. PubMed ID: 17711328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell viability in a wet silica gel.
    Nieto A; Areva S; Wilson T; Viitala R; Vallet-Regi M
    Acta Biomater; 2009 Nov; 5(9):3478-87. PubMed ID: 19481618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin.
    Prokopowicz M; Przyjazny A
    J Microencapsul; 2007 Nov; 24(7):682-701. PubMed ID: 17763062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular phospholipid gel-based depot formulations for pharmaceutical proteins: development and in vitro evaluation.
    Tian W; Schulze S; Brandl M; Winter G
    J Control Release; 2010 Mar; 142(3):319-25. PubMed ID: 19925833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of surface coating on the controlled release of vitamin B1 from mesoporous silica tablets.
    Wu Z; Jiang Y; Kim T; Lee K
    J Control Release; 2007 Jun; 119(2):215-21. PubMed ID: 17434225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
    Xie J; Wang CH
    Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation.
    Kofuji K; Akamine H; Qian CJ; Watanabe K; Togan Y; Nishimura M; Sugiyama I; Murata Y; Kawashima S
    Int J Pharm; 2004 Mar; 272(1-2):65-78. PubMed ID: 15019070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.